HIF1A and cancer: Notably, HIF1α activates the expression of genes such as MDR1/P-glycoprotein (P-gp), a key efflux pump involved in multidrug resistance, which expels chemotherapeutic drugs from cancer cells, reducing their intracellular levels and effectiveness (56).